🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Jiangsu Hengrui Medicine Co Ltd (600276)

Shanghai
Currency in CNY
49.43
-0.07(-0.14%)
Closed
600276 Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
48.3049.67
52 wk Range
35.5157.53
Key Statistics
Edit
Bid/Ask
49.48 / 49.49
Prev. Close
49.5
Open
48.99
Day's Range
48.3-49.67
52 wk Range
35.51-57.53
Volume
58,679,168
Average Volume (3m)
40,993,597
1-Year Change
2.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600276 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
59.72
Upside
+20.82%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Jiangsu Hengrui Medicine Co Ltd Company Profile

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811, SHR1459, Mecapegfilgrastim, Apatinib, Linperlisib, and SHR2554 for oncology indications; SHR4640, Retagliptin, SHR20004, SHR-1209, SHR3824, INS068, SHR7280, and SHR2285 for cardiovascular and metabolism indications. It is also developing SHR0302, Hetrombopag, Vunakizumab, and SHR-1703 for autoimmune indications; SHR0410, Imrecoxib, Remimazolam, and SHR8554 for pain; Oteseconazole and HRS9950 for anti-infection; and SHR8028, SHR8058, SHR-1707, and SHR-1222 for other indications. The company was founded in 1970 and is based in Lianyungang, China.

Employees
20636
Market
China

Compare 600276 to Peers and Sector

Metrics to compare
600276
Peers
Sector
Relationship
P/E Ratio
57.8x18.1x−0.6x
PEG Ratio
1.88−0.520.00
Price/Book
7.2x2.2x2.6x
Price / LTM Sales
12.1x2.4x3.2x
Upside (Analyst Target)
16.0%15.5%43.4%
Fair Value Upside
Unlock19.2%6.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.86
Dividend Yield
0.40%
Industry Median 1.41%
Annualised payout
0.2000
Paid annually
5-Years Growth
+9.46%
Growth Streak

FAQ

What Is the Jiangsu Hengrui (600276) Stock Price Today?

The Jiangsu Hengrui stock price today is 49.43

What Stock Exchange Does Jiangsu Hengrui Trade On?

Jiangsu Hengrui is listed and trades on the Shanghai stock exchange.

What Is the Stock Symbol for Jiangsu Hengrui?

The stock symbol for Jiangsu Hengrui is "600276."

Does Jiangsu Hengrui Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.40%.

What Is the Jiangsu Hengrui Market Cap?

As of today, Jiangsu Hengrui market cap is 314.11B.

What is Jiangsu Hengrui Earnings Per Share?

The Jiangsu Hengrui EPS is 0.86.

What Is the Next Jiangsu Hengrui Earnings Date?

Jiangsu Hengrui will release its next earnings report on 20 Apr 2025.

From a Technical Analysis Perspective, Is 600276 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.